21. Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE. (21st January 2015) Authors: Papp, K.A.; Barber, K.; Bissonnette, R.; Bourcier, M.; Lynde, C.W.; Poulin, Y.; Shelton, J.; Garces, K.; Toole, J.; Poulin‐Costello, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 8(2015:Aug.) Page Start: 1555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Incidence of cardiovascular events among tildrakizumab‐treated patients with moderate‐to‐severe plaque psoriasis: pooled data from three large randomised clinical trials. (30th August 2019) Authors: Bissonnette, R.; Fernández‐Peñas, P.; Puig, L.; Mendelsohn, A.M.; Rozzo, S.J.; Menter, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 1(2020) Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Increase in coronary atherosclerosis severity and the prevalence of coronary artery mixed plaques in patients with psoriasis. (1st March 2017) Authors: Bissonnette, R.; Cademartiti, F.; Maffei, E.; Tardif, J.‐C. Journal: British journal of dermatology Issue: Volume 176:Number 3(2017) Page Start: 800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Increase in coronary atherosclerosis severity and the prevalence of coronary artery mixed plaques in patients with psoriasis. (26th October 2016) Authors: Bissonnette, R.; Cademartiti, F.; Maffei, E.; Tardif, J.‐C. Journal: British journal of dermatology Issue: Volume 176:Number 3(2017) Page Start: 800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Increased expression of IL‐17A and limited involvement of IL‐23 in patients with palmo‐plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial. (24th September 2013) Authors: Bissonnette, R.; Nigen, S.; Langley, R.G.; Lynde, C.W.; Tan, J.; Fuentes‐Duculan, J.; Krueger, J.G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 10(2014:Oct.) Page Start: 1298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Ixekizumab efficacy and safety in moderate‐to‐severe genital psoriasis. (1st October 2018) Authors: Ryan, C.; Menter, A.; Guenther, L.; Blauvelt, A.; Bissonnette, R.; Meeuwis, K.; Sullivan, J.; Cather, J.C.; Yosipovitch, G.; Gottlieb, A.B.; Merola, J.F.; Callis Duffin, K.; Fretzin, S.; Osuntokun, O.O.; Burge, R.; Naegeli, A.N.; Yang, F.E.; Lin, C.‐Y.; Todd, K.; Potts Bleakman, A. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: e177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis. (14th February 2018) Authors: Bissonnette, R. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis. (1st February 2018) Authors: Bissonnette, R. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Long‐term efficacy of ustekinumab in patients with moderate‐to‐severe psoriasis treated for up to 5 years in the PHOENIX 1 study. (20th December 2012) Authors: Kimball, A.B.; Papp, K.A.; Wasfi, Y.; Chan, D.; Bissonnette, R.; Sofen, H.; Yeilding, N.; Li, S.; Szapary, P.; Gordon, K.B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 27:Number 12(2013:Dec.) Page Start: 1535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. OP0169 The Effects of TNF Inhibitors, Methotrexate, NSAIDS and Corticosteroids on Cardiovascular Events in Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-Analysis. (10th June 2014) Authors: Roubille, C.; Richer, V.; Starnino, T.; McCourt, C.; McFarlane, A.; Fleming, P.; Siu, S.; Kraft, J.; Lynde, C.; Pope, J.; Keeling, S.; Gulliver, W.; Dutz, J.; Bessette, L.; Bissonnette, R.; Haraoui, B. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗